NASDAQ:GHSI
Guardion Health Sciences Inc. Stock News
$9.75
-0.140 (-1.42%)
At Close: Jul 02, 2024
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-ba
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
03:00pm, Thursday, 23'rd May 2024
Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution
Guardion Health Sciences Announces
05:01pm, Monday, 13'th May 2024
-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Up
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
06:15am, Friday, 29'th Mar 2024
Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022
Why Is Guardion Health (GHSI) Stock Up 66% Today?
10:54am, Wednesday, 31'st Jan 2024
Guardion Health Sciences (NASDAQ: GHSI ) stock is rocketing higher on Wednesday after the company announced an agreement to sell its Activ Nutritional subsidiary. Doctor's Best is acting as the buyer
What made Guardion Health stock double on Wednesday?
08:47am, Wednesday, 31'st Jan 2024
Guardion Health Sciences Inc (NASDAQ: GHSI) is up nearly 100% this morning after Doctor's Best Inc agreed to buy its Activ Nutritional LLC. Could Guardion Health stock climb any further?
HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
04:10pm, Monday, 13'th Nov 2023
Viactiv ® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
08:15am, Monday, 14'th Aug 2023
Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonst
Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements
09:05pm, Tuesday, 24'th Jan 2023 GlobeNewswire Inc.
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
06:42pm, Monday, 09'th Jan 2023 Benzinga
Gainers
CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Apexigen, Inc. (NASDAQ: APGN) jumped 111% to
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
03:36pm, Monday, 09'th Jan 2023 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
CinCor Pharma, Inc. (NASDAQ: CINC) shares surged
Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023
09:15pm, Friday, 06'th Jan 2023 GlobeNewswire Inc.
HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its com
7 Penny Stocks That Actually Have Buy Ratings
07:18am, Thursday, 01'st Dec 2022
This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about companies that retail investors cannot obtain.
Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock
10:06pm, Tuesday, 29'th Nov 2022 GlobeNewswire Inc.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based,